MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Proceeds from issuance ofcommon shares for cash,...$6,151K Proceeds from issuance ofconvertible notes, net$419K Proceeds from issuance ofconvertible notes, net -...$189K Proceeds from exercise ofwarrants$132K Net cash provided byfinancing activities$6,867K Canceled cashflow$24K Net change in cashand cash...-$1,738K Canceled cashflow$6,867K Accounts payable andaccrued liabilities$1,308K Stock-based compensation$1,142K Loss onextinguishment of debt$825K Loss onextinguishment of debt - related...$333K Accounts payable -related parties$283K Amortization of debtdiscounts and debt...$146K Prepaid expenses andother current assets-$129K Amortization of debtdiscounts and debt...$62K Net change in fairvalue of digital...$62K Accrued interest$48K Non-cash lease expense$35K Accrued interest -related party$21K Proceeds fromdisposition of digital...-$188K Repayment of convertiblenote$24K Net cash used inoperating activities-$8,520K Canceled cashflow$4,394K Net cash (used in)provided by investing...-$62K Effect of exchange ratechanges on cash-$23K Canceled cashflow$188K Net loss$12,879K Fixed cash paymentsrelated to operating...-$35K Purchase of digitalassets$250K
Cash Flow
source: myfinsight.com

ARTELO BIOSCIENCES, INC. (ARTL)

ARTELO BIOSCIENCES, INC. (ARTL)